title: Diabetes medications and bone.
abstract: Type 2 diabetes mellitus (T2DM) is a common chronic disease that may be associated with an increased risk of fracture. Evidence that thiazolidinediones (TZDs) increase fracture risk in women with T2DM has focused attention on the skeletal effects of treatments for diabetes. Only scant, low-quality evidence is available for non-TZD diabetes medications and bone health, but it suggests that there are no clinically important effects.
authors.affiliation: Department of Medicine, University of Auckland, Private Bag 92019, Auckland, New Zealand, a.grey@auckland.ac.nz.
authors.forename: Andrew
authors.initials: A
authors.lastname: Grey
mesh_terms: D001842:Bone and Bones / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D050723:Fractures, Bone / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents